Related Experiment Videos
Neurotoxicities of current leukemia therapy
The American Journal of Pediatric Hematology/Oncology
|January 1, 1979
Summary
Treatment for acute leukemia can cause significant neurotoxicity, affecting the central nervous system. Early detection and management of this neurological complication are crucial for preventing irreversible damage.
Area of Science:
- Oncology
- Neurology
- Clinical Medicine
Background:
- Acute leukemia treatments have advanced, but therapy complications remain a concern.
- Neurotoxicity is a significant complication, often linked to central nervous system prophylaxis.
- This neurotoxicity can manifest acutely or be delayed, with varying severity.
Purpose of the Study:
- To review the clinical and physical aspects of neurotoxicity.
- To discuss neurotoxicity related to cranial irradiation and chemotherapy in leukemia treatment.
- To provide recommendations for managing treatment-related neurotoxicity.
Main Methods:
- Literature review of clinical and physical manifestations of neurotoxicity.
- Analysis of neurotoxicity associated with cranial irradiation and chemotherapy.
- Development of guidelines for monitoring, evaluation, and treatment.
Main Results:
- Neurotoxicity presents with diverse clinical and physical symptoms.
- Both cranial irradiation and chemotherapy contribute to neurotoxicity.
- Timely intervention can potentially ameliorate neurological sequelae.
Conclusions:
- Understanding and monitoring neurotoxicity in acute leukemia patients is vital.
- Recommendations are provided for the clinical management of neurotoxicity.
- Proactive management may improve patient outcomes and prevent long-term neurological deficits.